Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 21.18%49.65B | 12.43%40.97B | 9.15%10.42B | 12.77%9.83B | 10.65%10.69B | 17.79%10.03B | 43.25%36.44B | 25.14%9.55B | 40.47%8.72B | 48.74%9.66B |
| Cost of revenue | 20.61%33.19B | 4.49%27.52B | 11.87%7.51B | 3.40%6.78B | 0.86%6.67B | 1.64%6.56B | 14.47%26.34B | 12.23%6.72B | 12.20%6.56B | 14.86%6.61B |
| Gross profit | 22.35%16.45B | 33.14%13.45B | 2.72%2.91B | 41.17%3.05B | 31.87%4.01B | 68.31%3.47B | 315.73%10.1B | 72.01%2.83B | 496.43%2.16B | 314.13%3.04B |
| Operating expense | 20.37%10.15B | 31.62%8.43B | 23.61%2.46B | 29.52%1.98B | 38.54%2.12B | 37.96%1.87B | 39.59%6.4B | 63.43%1.99B | 42.68%1.53B | 26.80%1.53B |
| Operating profit | 25.66%6.31B | 35.76%5.02B | -46.79%447M | 69.24%1.07B | 25.12%1.89B | 126.20%1.61B | 271.33%3.7B | 96.48%840M | 189.49%634M | 420.28%1.51B |
| Net non-operating interest income (expenses) | -94.77%-559M | 17.05%-287M | 1.32%-75M | 68.30%-71M | -222.73%-71M | -191.67%-70M | -96.60%-346M | -182.18%-76M | -678.81%-224M | 76.95%-22M |
| Non-operating interest expense | -0.70%282M | 97.22%284M | -1.33%74M | 200.00%69M | 222.73%71M | 191.67%70M | 37.67%144M | 183.95%75M | -12.43%23M | -18.20%22M |
| Total other finance cost | 9,133.33%277M | -98.51%3M | 0.00%1M | ---- | ---- | ---- | 180.86%202M | 61.03%1M | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 52.44%-107M | 41.71%-225M | -37.42%-224M | 0 | 99.62%-1M | 0 | -248.37%-386M | -37.61%-163M | 42M | -21,133.97%-265M |
| Less:Other special charges | -119.63%-21M | -52.02%107M | --106M | --0 | ---- | ---- | 3,015.41%223M | --0 | ---42M | ---- |
| Less:Write off | 8.47%128M | -27.61%118M | ---- | ---- | ---- | ---- | 37.61%163M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -1.03%96M | -30.71%97M | -27.03%27M | -58.46%27M | -9.09%30M | 160.00%13M | -54.90%140M | -5.62%37M | -79.75%65M | 144.56%33M |
| Income before tax | 24.61%5.74B | 48.24%4.6B | -72.57%175M | 98.27%1.03B | 47.10%1.85B | 124.31%1.55B | 245.60%3.11B | 97.54%638M | 224.70%519M | 295.45%1.26B |
| Income tax | 267.02%476M | 73.76%-285M | 70.70%-332M | 0.00%16M | 0.00%16M | 0.00%15M | -2,453.76%-1.09B | -76,765.67%-1.13B | 0.81%16M | 0.81%16M |
| Net income | 7.61%5.26B | 16.63%4.89B | -71.39%507M | 101.59%1.01B | 47.82%1.83B | 126.92%1.53B | 292.36%4.19B | 446.17%1.77B | 216.42%503M | 288.16%1.24B |
| Net income continuous operations | 7.61%5.26B | 16.63%4.89B | -71.37%507M | 101.39%1.01B | 47.70%1.83B | 127.07%1.54B | 292.36%4.19B | 445.86%1.77B | 216.42%503M | 288.32%1.24B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 7.61%5.26B | 16.63%4.89B | -71.39%507M | 101.59%1.01B | 47.82%1.83B | 126.92%1.53B | 292.36%4.19B | 446.17%1.77B | 216.42%503M | 288.16%1.24B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 7.61%5.26B | 16.63%4.89B | -71.39%507M | 101.59%1.01B | 47.82%1.83B | 126.92%1.53B | 292.36%4.19B | 446.17%1.77B | 216.42%503M | 288.16%1.24B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 9.13%368.9 | 10.71%338.03 | -74.91%31.66 | 125.34%68.21 | 32.98%128.11 | 109.58%110.05 | 280.46%305.33 | 400.83%126.21 | 190.20%30.27 | 288.27%96.34 |
| Diluted earnings per share | 9.13%368.9 | 18.64%338.03 | -73.17%31.66 | 137.33%68.21 | 43.22%128.11 | 125.74%110.05 | 268.40%284.93 | 368.28%117.99 | 185.64%28.74 | 274.78%89.45 |
| Dividend per share | 52.17%35 | 155.56%23 | 155.56%23 | 0 | 0 | 0 | 9 | 9 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |